Metabolic record of patients with history of gestational diabetes. Follow-up of patients for six years (2013-2019)

Authors

  • Jorge Olivares Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina
  • Marisol Olivares Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina
  • Luciana Grilli Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina
  • Carina Verdasco Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina
  • Carolina Miglianelli Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

DOI:

https://doi.org/10.47196/diab.v55i1.472

Keywords:

gestational diabetes, type 2 diabetes mellitus postnatal screening, diagnostic criteria, maternal outcomes, fetal outcomes

Abstract

Introduction: there is no register of the number of women with gestational diabetes (GD) that have undergone metabolic post-partum control in the province of La Pampa, even though it is well-known the increased associated risk of becoming a diabetes type 2 patient (T2DM).

Objectives: to analyze at the Interzonal Public Hospital (Dr. Lucio Molas) the percentage of women with GD who returned to postpartum metabolic control and developed T2DM during six years of follow-up.

Materials and methods: descriptive ambispective study in 44 patients with GD diagnosed in 2013 with follow-up until 31 December 2019. Different characteristics were analyzed in all participants: previous history of GD and family members of diabetes (FHD), age, gestational week of the diagnosis with fasting glucose or oral glucose tolerance test (OGTT), body mass index (BMI), blood pressure, delivery route, newborn weight, glycated hemoglobin (HbA1C).

Results: in 2013, 1,238 deliveries were performed, 44 patients (3.7%) had diagnosed DG, 68% through OGTT. They presented 43% AFD, 38.6% overweight, 20.45% obesity, 68.2% cesarean sections and 11.4% newborns with high weight. In six years of follow-up, 54.5% of these patients underwent metabolic control; This group, unlike the group without control, presented a higher BMI at the beginning of the pregnancy (t:2.103; p<0.02), basal glycemia (t:10.59; p<0.001), systolic blood pressure (t:2.629 ; p<0.01), diastolic (t:1.965; p<0.05) and fetal macrosomia (4 vs 1). 33.3% manifested DM2 predominantly from three years postpartum.

Conclusions: 54.5% of the patients with DG attended late postpartum metabolic control, and 33.3% evolved to DM2; These patients even presented a greater number of obstetric and cardiometabolic risk factors than the group without control at the beginning of pregnancy.

Author Biographies

Jorge Olivares, Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

Head of the Department of Teaching and Research; Staff Physician; Endocrinology and Diabetes Service, Healthcare Establishment Dr. Lucio Molas; Senior Lecturer at the National University of la Pampa

Marisol Olivares, Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

Third-year resident of the Medical Clinic

Luciana Grilli, Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

Head of the Endocrinology and Diabetes Service

Carina Verdasco, Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

Obstetrics Graduate, Tocogynecology Service Plant

Carolina Miglianelli, Dr. Lucio Molas Healthcare Establishment, Santa Rosa, La Pampa, Argentina

Staff Physician

References

I. Guías de diagnóstico y tratamiento de la diabetes gestacional. ALAD 2016. Rev ALAD 2016; 6:155-69.

II. Chávez-Courtois M, Chelsea G I, Romero-Pérez G, et al. Experiencia y percepciones de la diabetes gestacional y su automanejo en un grupo de mujeres multíparas con sobrepeso. Ciência & Saúde Coletiva 2014; 19(6):1643-1652.

III. Nielsen K, Kapur A, Damm P, et al. From screening postpartum follow-up the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy and Childbirth 2014; 14:41. Disponible en: http://www.biomedcentral.com/1471-2393/14/41.

IV. Noctor E, Crowe C, Carmody L, et al. Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. European Journal of Endocrinology 2016; 175:287-297.

V. American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes. Diabetes Care 2019; 42 (Suppl 1):S165.

VI. Gorbán de Lapertosa S, Alvariñas J, Elgart J, et al. Educación terapéutica de mujeres con diabetes gestacional (Edugest): datos correspondientes al período de reclutamiento. Revista de la Sociedad Argentina de Diabetes 2019; Vol 53, Nº 3 Sup.

VII. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33(3):676-82.

VIII. Kugishima Y, Ichiro Y, Hiroshi Y, et al. Risk factors associated with the development of postpartum diabetes in Japanese women with gestational diabetes. BMC Pregnancy and Childbirth 2018; 18:19.

IX. Stogianni A, Lendahls L, Landin-Olsson M, et al. Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Pregnancy and Childbirth 2019; 19(1):159. Disponible en: https://doi.org/10.1186/s12884-019-2269-8.

X. Gorbán de Lapertosa S, Alvariñas J, Elgart JF, et al. The triad macrosomia, obesity, and hypertriglyceridemia in gestational diabetes. Diabetes Metab Res Rev. 2020 Feb; 18:e03302. DOI: 10.1002/dmrr.3302.

XI. Sanderson H, Loveman E, Colquitt J, et al. Improving uptake of postnatal checking of blood glucose in women who had gestational diabetes mellitus in Universal Healthcare Settings: a systematic review. J Clin Med 2019; 8:4. DOI:10.3390/jcm8010004 www.mdpi.com/journal/jcm.

XII. Calvo, EB, López LB, Balmaceda Y, et al. Reference charts for weight gain and body mass index during pregnancy obtained from a healthy cohort. The Journal of Maternal-Fetal &Neonatal Medicine 2009; 22(1):36-42.

XIII. Benhalima K, Lens K, Bosteels J, et al. The risk for glucose intolerance after gestational diabetes mellitus since the introduction of the IADPSG criteria: a systematic review and meta-analysis. J Clin Med 2019; 8(9):1431. DOI: 10.3390 /jcm8091431.

XIV. Lee AJ, Hiscock RJ, Wein P, et al. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes. A retrospective cohort study using survival analysis. Diabetes Care 2007; 30:878-883.

XV. Kramer C.K, Balakumar S, Anthony JH, et al. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of b-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum. Diabetes Care 2014; 37:3262-3269. DOI: 10.2337/dc14-1529.

XVI. Retnakaran R, Ying Qi, Mathew Sermer, et al. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008; 31:2026-31.

XVII. O'Reilly S L, Leonard Y, Dasgupta K, et al. Diabetes after pregnancy prevention trials: systematic review for core outcome set development. Matern Child Nutr 2020; e12947. Disponible en: wileyonlinelibrary.com/journal/mcn 1 of 11 https://doi.org/10.1111/mcn.12947.

XVIII. Wasalathanthri S. Attenuating type 2 diabetes with postpartum interventions following gestational diabetes mellitus. World J Diabetes 2015; 6(4): 648-653.

XIX. Oats JN, Beischer NA. The persistence of abnormal glucose tolerance after delivery. Obstet Gynecol 1990; 75:397-40.

XX. Carr DB, Newton KM, Utzschneider KM, et al. Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care 2008; 31:1037-39.

XXI. Olmos PR, Rigotti A, Busso D, Berkowitz L, Santos JL, Borzone GR, et al. Maternal hypertriglyceridemia: a link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity (Silver Spring) 2014; 22:2156-63.

XXII. Sesmilo G, Meler E, Perea V, et al. Glucemia materna en ayunas y resultados adversos del embarazo en una población mediterránea. Acta Diabetol 2017; 54:293-299. Disponible en: https://doi.org/10.1007/s00592-016-0952-z

XXIII. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373:1773-1779.

XXIV. Cuarta Encuesta Nacional de Factores de Riesgo. Resultados preliminares. 1º Ed. Ciudad Autónoma de Buenos Aires: Instituto Nacional de Estadísticas y Censos (INDEC), Secretaría de Gobierno de Salud 2019. ISBN 978-950-896-542-4.

Published

2021-04-01

How to Cite

Olivares, J., Olivares, M., Grilli, L., Verdasco, C., & Miglianelli, C. (2021). Metabolic record of patients with history of gestational diabetes. Follow-up of patients for six years (2013-2019). Journal of the Argentine Society of Diabetes, 55(1), 13–20. https://doi.org/10.47196/diab.v55i1.472

Issue

Section

Original article

Most read articles by the same author(s)